Company intelligence / Profile preview

McQuade Center for Strategic Research and Development

Princeton, New Jersey, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

MSRD funds and operationally supports early-stage programs, notably: - ACH000029 for anxiety/PTSD (phase 1b with Aché)[4] - Several families of next-generation psychedelic small molecules for mental illness (preclinical to phase 1a/b with Mindset Pharma)[5] Clinical data not yet available; programs are in early clinical or preclinical phases.

Therapeutic areas: NephrologyNeurologyPsychiatry
Modalities: Small moleculeDigital therapeuticsPsychedelic compoundPotential: Biologic
Industry: Pharma

Partnerships

Aché Laboratórios Farmacêuticos S.A. (co-development, CNS)[4]Mindset Pharma (novel psychedelic compounds)[5]Mindful Mamas (digital maternal mental health app investment)[3]

Beyond the preview

Go deeper on McQuade Center for Strategic Research and Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on McQuade Center for Strategic Research and Development.

Explore the full profile